Skip to main content
logo
Neurothera Labs Inc. (TSXV:NTLX)
Canada flag Canada · Delayed Price · Currency is CAD
0.3250
+0.0350 (12.07%)
Aug 11, 2026, 1:26 PM EST

Neurothera Labs Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Cash & Equivalents
1.70.12
Cash & Short-Term Investments
1.70.12
Cash Growth
1353.85%-
Accounts Receivable
0.010.01
Other Receivables
0.070.04
Receivables
0.080.05
Inventory
0.080.11
Restricted Cash
0.010.01
Total Current Assets
1.860.29
Other Intangible Assets
1.171.48
Total Assets
3.031.76

Liabilities

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Accounts Payable
0.350.02
Accrued Expenses
0.330.19
Current Portion of Long-Term Debt
0.36-
Other Current Liabilities
0.340.02
Total Current Liabilities
1.380.23
Long-Term Debt
0.58-
Other Long-Term Liabilities
0.43-
Total Liabilities
2.390.23

Shareholders' Equity

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Additional Paid-In Capital
25.15.56
Retained Earnings
-24.96-20.84
Comprehensive Income & Other
-16.06
Total Common Equity
0.130.78
Minority Interest
0.510.75
Shareholders' Equity
0.651.54
Total Liabilities & Equity
3.031.76

Additional Metrics

Fiscal Year
FY 2025FY 2024
Period Ending
Dec '25 Dec '24
Total Debt
0.93-
Net Cash (Debt)
0.770.12
Net Cash Growth
555.56%-
Net Cash Per Share
0.010.00
Filing Date Shares Outstanding
84.963.3
Total Common Shares Outstanding
84.963.3
Working Capital
0.490.06
Book Value Per Share
0.000.01
Tangible Book Value
-1.04-0.7
Tangible Book Value Per Share
-0.01-0.01